Evidence mapPaperPMID 38892006Full record

ArticleInternational journal of molecular sciences2024

Systemic Inflammation in Oncologic Patients Undergoing Systemic Treatment and Receiving Whey Protein-Based Nutritional Support.

Aura D Herrera-Martínez, Ana Navas Romo, Soraya León-Idougourram, Concepción Muñoz-Jiménez, Rosa Rodríguez-Alonso, Gregorio Manzano García, Marta Camacho-Cardenosa, Antonio Casado-Diaz, María Ángeles Gálvez-Moreno, María José Molina Puertas and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aura D Herrera-MartínezMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Ana Navas RomoMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Soraya León-IdougourramMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Concepción Muñoz-JiménezMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Rosa Rodríguez-AlonsoMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Gregorio Manzano GarcíaMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Marta Camacho-CardenosaMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Antonio Casado-DiazMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-8520-8278
María Ángeles Gálvez-MorenoMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
María José Molina PuertasMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Aurora Jurado RogerMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0001-9092-8758

Funding

Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union PI23/01554 , JR19/00050
6 · The paper itself

Abstract

There is increasing evidence about the role of inflammation in sarcopenia and tumor progression; thus, its modulation would represent a valuable strategy for improving clinical outcomes in patients with cancer. Several studies have reported that whey protein has significant anti-inflammatory and antioxidant characteristics in humans. We aimed to evaluate the effects of whey protein-based oral nutritional support on circulating cytokines in patients with solid tumors undergoing systemic treatment. Forty-six patients with solid tumors of different origin and undergoing systemic treatment were evaluated. Nutritional support with two daily whey protein-based oral supplements was administered. Circulating levels of IL-6, IL-8, IL-10, MCP-1 and IP-10 were determined. Nutritional evaluation included anthropometric, instrumental and biochemical parameters. Over 63% of the evaluated patients underwent surgery, 56.5% required chemotherapy and almost 50% received combined treatment. Patients with resected primary tumor presented with lower baseline IL-6 (

Indexed as

CytokinesInflammationNeoplasmsNutritional SupportWhey ProteinsAdultAgedChemokine CCL2Dietary SupplementsFemaleHumansMaleMiddle AgedChemokine CCL2CytokinesWhey Proteinscancercytokinesinflammationwhey protein

Identifiers

PMID38892006
PMCPMC11171732

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.